Share
Resistance to Targeted Therapies in Breast Cancer (in English)
Prosperi, Jenifer R. (Author)
·
Springer
· Paperback
Resistance to Targeted Therapies in Breast Cancer (in English) - Prosperi, Jenifer R.
$ 113.67
$ 119.99
You save: $ 6.32
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My WishlistsIt will be shipped from our warehouse between
Friday, June 07 and
Monday, June 10.
You will receive it anywhere in United States between 1 and 3 business days after shipment.
Synopsis "Resistance to Targeted Therapies in Breast Cancer (in English)"
We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast cancer (i.e., EGFR and Wnt signaling). We have also provided an overview of standard of care as an introduction into the importance of targeted therapy. It is our hope that this volume gives an insight into the landscape of breast cancer treatment, the challenges of targeted therapy, and a glimpse into the future of breast cancer therapy.
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.
✓ Producto agregado correctamente al carro, Ir a Pagar.
